The critical role for malignancy of stromal CD44 is further supported by a study that shows that mesenchymal stem cells require CD44 to be transformed into CAF in a conditioned media assay as well as in vivo recruitment to a tumor site [12]. This evidence concerns the gene CD44 and neoplasm.